JCR Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 3/6
JCR Pharmaceuticals is a dividend paying company with a current yield of 2.71%. Next payment date is on 6th December, 2024 with an ex-dividend date of 27th September, 2024.
Key information
2.7%
Dividend yield
-0.02%
Buyback Yield
Total Shareholder Yield | 2.7% |
Future Dividend Yield | 2.8% |
Dividend Growth | 17.3% |
Next dividend pay date | 06 Dec 24 |
Ex dividend date | 27 Sep 24 |
Dividend per share | €0.120 |
Payout ratio | -286% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: JCR's dividends per share have been stable in the past 10 years.
Growing Dividend: JCR's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
JCR Pharmaceuticals Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (JCR) | 2.7% |
Market Bottom 25% (DE) | 1.7% |
Market Top 25% (DE) | 4.8% |
Industry Average (Pharmaceuticals) | 1.4% |
Analyst forecast (JCR) (up to 3 years) | 2.8% |
Notable Dividend: JCR's dividend (2.71%) is higher than the bottom 25% of dividend payers in the German market (1.74%).
High Dividend: JCR's dividend (2.71%) is low compared to the top 25% of dividend payers in the German market (4.76%).
Earnings Payout to Shareholders
Earnings Coverage: JCR is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (562.7%), JCR's dividend payments are not well covered by cash flows.